Ardelyx, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States501-1000 Employees
Ardelyx, Inc. is a biotechnology research company headquartered in Waltham, Massachusetts, with an employee base of about 201-500. It operates as a commercial-stage biopharmaceutical company focused on developing and commercializing medicines that address significant unmet medical needs. The company has two U.S. approved commercial products, IBSRELA (tenapanor) and XPHOZAH (tenapanor). Its pipeline includes the Phase 3 development of IBSRELA for chronic idiopathic constipation and RDX10531, a next-generation NHE3 inhibitor with potential applications across multiple therapeutic areas. Ardelyx partners with other organizations to develop and market its products outside the United States.